• 1. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Benzoylindoles

Introduction to (3-chlorophenyl)-(1H-indol-3-yl)methanone (CAS No. 405275-16-3)

Compound (3-chlorophenyl)-(1H-indol-3-yl)methanone, with the chemical identifier CAS No. 405275-16-3, is a significant molecule in the realm of pharmaceutical chemistry and bioorganic synthesis. This compound, featuring a structural motif of a benzophenone derivative linked to an indole ring, has garnered considerable attention due to its potential pharmacological properties and synthetic utility.

The molecular structure of (3-chlorophenyl)-(1H-indol-3-yl)methanone consists of a benzene ring substituted with a chlorine atom at the 3-position, connected via a methanone bridge to an indole moiety. This unique arrangement of heterocyclic and aromatic systems makes it a versatile scaffold for further derivatization and functionalization, which is crucial in the development of novel therapeutic agents.

In recent years, there has been a growing interest in indole derivatives due to their wide range of biological activities. Indoles are known for their role in various physiological processes and have been extensively studied for their potential in treating conditions such as cancer, inflammation, and neurological disorders. The presence of the indole ring in (3-chlorophenyl)-(1H-indol-3-yl)methanone suggests that this compound may exhibit similar bioactivities, making it a promising candidate for further investigation.

One of the key areas where this compound has shown promise is in the field of oncology. Recent studies have demonstrated that indole derivatives can modulate various signaling pathways involved in cancer cell proliferation and survival. Specifically, the indole moiety in (3-chlorophenyl)-(1H-indol-3-yl)methanone may interact with targets such as transcription factors and kinases, leading to the inhibition of tumor growth. Additionally, the chlorine substituent on the benzene ring could enhance the metabolic stability and bioavailability of the compound, which are critical factors for its efficacy as an anticancer agent.

Another area of interest is the potential use of (3-chlorophenyl)-(1H-indol-3-yl)methanone in treating neurological disorders. Emerging research indicates that indole derivatives can cross the blood-brain barrier and exert neuroprotective effects. The structural features of this compound may allow it to interact with neurotransmitter receptors and ion channels, potentially offering therapeutic benefits in conditions such as Alzheimer's disease and Parkinson's disease. Furthermore, its ability to modulate inflammatory responses may also contribute to its potential as a treatment for neuroinflammatory diseases.

The synthetic pathways for (3-chlorophenyl)-(1H-indol-3-yl)methanone are another aspect that has been thoroughly investigated. The compound can be synthesized through various methods, including condensation reactions between 3-chlorobenzaldehyde and tryptophan derivatives or through palladium-catalyzed cross-coupling reactions. These synthetic approaches highlight the versatility of this scaffold and its potential for large-scale production.

In conclusion, (3-chlorophenyl)-(1H-indol-3-yl)methanone (CAS No. 405275-16-3) is a multifaceted compound with significant potential in pharmaceutical applications. Its unique structural features make it an attractive scaffold for further derivatization and functionalization, leading to novel therapeutic agents with applications in oncology, neurology, and other areas. As research continues to uncover new biological activities and synthetic methodologies, this compound is poised to play a crucial role in the development of next-generation pharmaceuticals.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)